April 8, 2025 - 10:03

Acrisure LLC has announced significant leadership changes, appointing Mark Wassersug as the new Chief Technology Officer and Shawn Pelsinger as Chief Administrative Officer. Wassersug, who previously held a prominent position at Intercontinental Exchange Inc., brings a wealth of experience in technology and innovation to Acrisure. His expertise is expected to drive the company's technological advancements and enhance its digital offerings.
Meanwhile, Pelsinger joins Acrisure from Palantir Technologies Inc., where he played a crucial role in administrative functions. His background in managing complex operations will be instrumental as Acrisure seeks to streamline its administrative processes and improve overall efficiency.
These strategic appointments reflect Acrisure's commitment to strengthening its leadership team in order to navigate the rapidly evolving landscape of the financial services industry. The company aims to leverage the skills and experiences of its new executives to foster growth and drive innovation in the coming years.
February 9, 2026 - 08:29
QuantumScape CTO on Eagle Line and scaling solid-state techThe race to commercialize solid-state batteries, a technology promising safer, longer-range electric vehicles, is entering a critical new phase. A key leader at QuantumScape has detailed the...
February 7, 2026 - 02:44
Getting Our Future Out of Traffic: Boston Pilots Emerging Transportation Technology for School BussesDuring the spring of 2025, Boston Public Schools achieved historic highs in on-time bus performance, hitting 94% in both March and June—a milestone that reflects years of systematic improvements...
February 6, 2026 - 05:07
Microchip Technology (NASDAQ:MCHP) Beats Q4 Sales TargetsAnalog semiconductor leader Microchip Technology has announced financial results that exceeded market expectations for its fourth quarter. The company reported revenue of $1.19 billion, marking a...
February 5, 2026 - 22:23
Commentary urges balance between research integrity and technology transfer in biomedicineAs federal policymakers consider significant changes to the funding and regulation of U.S. biomedical research, a leading scientist emphasizes the critical need to maintain a careful equilibrium....